Trial Profile
A phase I trial of BHV-5000 solution formulation
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 19 Jan 2018
Price :
$35
*
At a glance
- Drugs BHV 5000 (Primary)
- Indications Neurological disorders; Rett syndrome
- Focus Adverse reactions
- Sponsors AstraZeneca
- 19 Jan 2018 New trial record